Olof has an academic background with a Ph.D. Pharmacology and a Postdoc Electrophysiology at Karolinska Institute. He brings a long experience heading up research teams at international companies like Eli Lilly Inc. (US) and Astra Zeneca ranging a number of clinical areas such neurodegenerative diseases. Most recently, he has been working as a consultant in various roles in startups and smaller biotech companies and strategic work with large pharma. He has published over 90 original papers in international peer-reviewed journals, several in prestigious journals such as Science, Nature and Cell.
CEO Rain Eriksoo said, “We are delighted to have Olof join Cavidi, I’m convinced that Olof will be a valuable member of the management group and lead the R&D team in all projects as well as driving future product road map initiatives.”